Milademetan
Milademetan is an investigational new drug that is being evaluated to treat liposarcoma. It is a MDM2 inhibitor.
Milademetan is an investigational new drug that is being evaluated to treat liposarcoma. It is a MDM2 inhibitor.
Milademetan is an investigational new drug that is being evaluated to treat liposarcoma. It is a MDM2 inhibitor.
Source: Wikipedia "Milademetan" · CC BY-SA 4.0
Share this article: X · Bluesky